Italy: estimated market value of biosimilars 2018-2022, by type

Published by
Juliette Gagliardi,
Dec 19, 2022
This statistic shows the estimated market value of biosimilars in Italy between 2018 and 2022, by type of originator. According to data, the biosimilar produced from Adalimumab is expected to generate a market value of 1,866 million euros between 2018 and 2022, while the market value of Trastuzumab biosimilar is forecasted to reach 1,738 million euros, in the same period.

Estimated market value of biosimilars in Italy between 2018 and 2022, by type of originator*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2018

Region

Italy

Survey time period

2018

Supplementary notes

*Biopharmaceutical products becoming off-patent between 2017 and 2022.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Generics and biosimilars in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars in Italy

Global overview

5

Generic drugs overview

7

Generics' expenditure

5

Generics' consumption

3

Biosimilar drugs

5

Outlook

5

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilars in ItalyTop pharmaceutical drugsHealth and food supplements market in ItalyNon-prescription drugs in ItalyPharmaceutical market in Italy
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.